nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—GCH1—Parkinson's disease	0.231	0.254	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—GCH1—Parkinson's disease	0.16	0.176	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of folate and pterines—MTHFR—Parkinson's disease	0.0729	0.0802	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MCCC1—Parkinson's disease	0.0557	0.0612	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—MTHFR—Parkinson's disease	0.0294	0.0323	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—INSR—Parkinson's disease	0.0266	0.0293	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—Parkinson's disease	0.0264	0.0291	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.0258	0.0284	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—SOD1—Parkinson's disease	0.0187	0.0205	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—SOD2—Parkinson's disease	0.0168	0.0185	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—GPX1—Parkinson's disease	0.016	0.0176	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—MTHFR—Parkinson's disease	0.0148	0.0163	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—ABL1—Parkinson's disease	0.0143	0.0157	CbGpPWpGaD
Trimetrexate—DHFR—embryo—Parkinson's disease	0.0134	0.172	CbGeAlD
Trimetrexate—Trimethoprim—ABCB1—Parkinson's disease	0.0133	1	CrCbGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.0119	0.0131	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—INS—Parkinson's disease	0.0118	0.013	CbGpPWpGaD
Trimetrexate—DHFR—cardiovascular system—Parkinson's disease	0.01	0.129	CbGeAlD
Trimetrexate—DHFR—Folate Metabolism—IL1B—Parkinson's disease	0.00878	0.00966	CbGpPWpGaD
Trimetrexate—DHFR—medulla oblongata—Parkinson's disease	0.00857	0.11	CbGeAlD
Trimetrexate—DHFR—midbrain—Parkinson's disease	0.00784	0.101	CbGeAlD
Trimetrexate—DHFR—spinal cord—Parkinson's disease	0.00765	0.0981	CbGeAlD
Trimetrexate—DHFR—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00754	0.0083	CbGpPWpGaD
Trimetrexate—DHFR—Disease—VPS35—Parkinson's disease	0.00709	0.0078	CbGpPWpGaD
Trimetrexate—DHFR—head—Parkinson's disease	0.0068	0.0872	CbGeAlD
Trimetrexate—DHFR—Cell Cycle—DCTN1—Parkinson's disease	0.00675	0.00742	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MCCC1—Parkinson's disease	0.00659	0.00725	CbGpPWpGaD
Trimetrexate—DHFR—nervous system—Parkinson's disease	0.00644	0.0827	CbGeAlD
Trimetrexate—DHFR—Folate Metabolism—TNF—Parkinson's disease	0.00637	0.00701	CbGpPWpGaD
Trimetrexate—DHFR—central nervous system—Parkinson's disease	0.0062	0.0796	CbGeAlD
Trimetrexate—DHFR—Disease—OMD—Parkinson's disease	0.00619	0.00682	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TALDO1—Parkinson's disease	0.00619	0.00682	CbGpPWpGaD
Trimetrexate—DHFR—cerebellum—Parkinson's disease	0.00606	0.0778	CbGeAlD
Trimetrexate—DHFR—Metabolism—ND3—Parkinson's disease	0.00552	0.00607	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MCCC1—Parkinson's disease	0.00552	0.00607	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—OMD—Parkinson's disease	0.00519	0.00571	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TALDO1—Parkinson's disease	0.00519	0.00571	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL6—Parkinson's disease	0.00514	0.00566	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TAF1—Parkinson's disease	0.00499	0.00549	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FBP1—Parkinson's disease	0.00499	0.00549	CbGpPWpGaD
Trimetrexate—DHFR—brain—Parkinson's disease	0.00492	0.0632	CbGeAlD
Trimetrexate—DHFR—Metabolism—NDUFB11—Parkinson's disease	0.00492	0.00541	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GCH1—Parkinson's disease	0.00469	0.00516	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FBP1—Parkinson's disease	0.00418	0.0046	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—DBH—Parkinson's disease	0.00418	0.0046	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GBA—Parkinson's disease	0.00418	0.0046	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SNCA—Parkinson's disease	0.00399	0.00439	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL6—Parkinson's disease	0.00399	0.00439	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—DDC—Parkinson's disease	0.00307	0.00338	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL23A—Parkinson's disease	0.00303	0.00333	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL14—Parkinson's disease	0.00303	0.00333	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA4—Parkinson's disease	0.0029	0.00319	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF20—Parkinson's disease	0.00282	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS8—Parkinson's disease	0.00282	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLA2G6—Parkinson's disease	0.00261	0.00287	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MAOB—Parkinson's disease	0.00258	0.00284	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ADRBK1—Parkinson's disease	0.00207	0.00228	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HSPA1A—Parkinson's disease	0.00206	0.00226	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2D6—Parkinson's disease	0.00192	0.00211	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CTGF—Parkinson's disease	0.00188	0.00207	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2E1—Parkinson's disease	0.00176	0.00193	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NQO1—Parkinson's disease	0.00174	0.00191	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TH—Parkinson's disease	0.00171	0.00188	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYCS—Parkinson's disease	0.00164	0.00181	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—COMT—Parkinson's disease	0.00146	0.0016	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTP1—Parkinson's disease	0.00145	0.00159	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MAOA—Parkinson's disease	0.00144	0.00159	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMOX1—Parkinson's disease	0.00143	0.00157	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—Parkinson's disease	0.0014	0.00155	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—Parkinson's disease	0.00137	0.00151	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—Parkinson's disease	0.00133	0.00146	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOE—Parkinson's disease	0.00131	0.00144	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPX1—Parkinson's disease	0.00127	0.0014	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—Parkinson's disease	0.00118	0.00129	CbGpPWpGaD
Trimetrexate—DHFR—Disease—INS—Parkinson's disease	0.00112	0.00123	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOE—Parkinson's disease	0.00109	0.0012	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—INS—Parkinson's disease	0.000935	0.00103	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—Parkinson's disease	0.000488	0.000537	CbGpPWpGaD
